PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION

被引:0
作者
Eng, G. [1 ,2 ]
Fana, V. [3 ]
Omerovic, E. [4 ]
Hojsgaard, P. [5 ]
Lindegaard, H. M. [6 ]
Jensen, E. K. [7 ]
Bouchelouche, P. N. [1 ]
机构
[1] Copenhagen Univ Hosp Koge, Koge, Region Zealand, Denmark
[2] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Dept Rheumatol, Parker Inst, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Glostrup, Denmark
[4] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Gentofte, Denmark
[6] Odense Univ Hosp, DK-5000 Odense, Denmark
[7] Copenhagen Univ Hosp Holbaek, Holbaek, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:230 / 230
页数:1
相关论文
共 3 条
[1]   Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up [J].
Bartelds, Geertje M. ;
Krieckaert, Charlotte L. M. ;
Nurmohamed, Michael T. ;
van Schouwenburg, Pauline A. ;
Lems, Willem F. ;
Twisk, Jos W. R. ;
Dijkmans, A. C. ;
Aarden, Lucien ;
Wolbink, Gerrit Jan .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (14) :1460-1468
[2]   Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab [J].
Bendtzen, Klaus ;
Geborek, Pierre ;
Svenson, Morten ;
Larsson, Lotta ;
Kapetanovic, Meliha C. ;
Saxne, Tore .
ARTHRITIS AND RHEUMATISM, 2006, 54 (12) :3782-3789
[3]   Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis [J].
Radstake, T. R. D. J. ;
Svenson, M. ;
Eijsbouts, A. M. ;
van den Hoogen, F. H. J. ;
Enevold, C. ;
van Riel, P. L. C. M. ;
Bendtzen, K. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) :1739-1745